Table 3.
Parameters for sensitivity analysis
| Variable | Value | Reference |
|---|---|---|
| Cost∗ | ||
| Transplant | ||
| Inpatient costs for ECMO-bridged transplant | Mean: $636,023 SD: $166,369 Min: $461,201 Max: $917,322 |
Patient-level data |
| Inpatient Costs for non–ECMO-bridged transplant | Mean: $538,928 SD: $157,331 Min: $317,404 Max: $836,799 |
Patient-level data |
| LVAD | ||
| Inpatient costs for ECMO-bridged LVAD | Mean: $769,471 SD: $500,431 Min: $317,201 Max: $1708,318 |
Patient-level data |
| Inpatient Costs for non–ECMO-Bridged LVAD | Mean: $325,242 SD: $114,812 Min: $160,363 Max: $504,643 |
Patient-level data |
| Survival after transplant | ||
| Years after transplant | ||
| ECMO-bridged survival | ||
| 1 Year | 0.70 | Mishra and colleagues, 201716 |
| 2 Year | 0.70 | Mishra and colleagues, 201716 |
| 5 Year | 0.70 | Mishra and colleagues, 201716 |
| 1 Year | 0.70 | Mishra and colleagues, 201716 |
| Non–ECMO-bridged survival | 0.86 | Long and colleagues, 201412 |
| 1 Year | 0.82 | Long and colleagues, 201412 |
| 3 Year | 0.79 | Long and colleagues, 201412 |
| 5 Year | 0.66 | Long and colleagues, 201412 |
| 7 Year | 0.86 | Long and colleagues, 201412 |
| Years after LVAD placement | ||
| ECMO-bridged survival | ||
| 1 Year | 0.77 | Han and colleagues, 201817 |
| Non–ECMO-bridged survival | ||
| 1 Year | 0.77 | Long and colleagues, 201412 |
| 2 Year | 0.62 | Long and colleagues, 201412 |
ECMO, Extracorporeal membranous oxygenation; SD, standard deviation; LVAD, left ventricular assist device.
∗
Cost in 2020 Dollars.